Related Experiment Video
Updated: Aug 16, 2026
06:39
Isolation and Purification of Bacterial Extracellular Vesicles from Human Feces Using Density Gradient Centrifugation
Published on: September 1, 2023
Gut microbiota-derived extracellular vesicles in Parkinson's disease
Sonja Karikka1,2,3, Mysore V Tejesvi2,4, Jenni Hekkala1,2
1Research Unit of Translational Medicine, University of Oulu, Oulu, Finland.
Iscience
|August 15, 2026
Summary
Gut bacteria release extracellular vesicles (EVs) that may play a role in Parkinson's disease (PD) development. Researchers found differences in these EVs between PD patients and healthy individuals, suggesting a link between gut microbiota and PD.
Area of Science:
- Microbiology
- Neuroscience
- Biochemistry
Background:
- The gut microbiota's role in Parkinson's disease (PD) pathophysiology is recognized, but the precise mechanisms remain unclear.
- Extracellular vesicles (EVs) are nanoscale particles released by cells, including microbes, carrying biomolecules across biological barriers.
Purpose of the Study:
- To investigate the hypothesis that gut microbiota-derived EVs influence Parkinson's disease (PD) pathophysiology.
- To analyze the characteristics and molecular cargo of EVs from the gut microbiota in PD patients.
Main Methods:
- Isolation of gut microbiota-derived EVs from fecal samples of PD patients and healthy controls.
- Analysis of EV concentration and particle size.
- 16S ribosomal RNA sequencing of gut microbiota and EVs.
- Proteomic analysis of EV protein content.
Main Results:
- PD patients exhibited higher concentrations of fecal EVs with larger mean particle size compared to controls.
- Significant taxonomic differences in gut microbiota and microbiota-derived EVs were observed between PD patients and controls.
- Unique protein signatures were identified in EVs from PD patients, suggesting disease-specific molecular cargo.
Conclusions:
- Gut microbiota-derived EVs represent a disease-relevant component in Parkinson's disease.
- The molecular cargo within these EVs may provide a mechanistic link between gut dysbiosis and PD pathophysiology.
- Further research into microbiota-derived EVs could reveal novel diagnostic or therapeutic targets for PD.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:38Intralumenal Vesicles and Multivesicular Bodies
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
01:36Overview of Exosomes
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...